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Abstract During purification oftau protein kinase I and II from 
the bovine brain extract, a new tau protein kinase was detected 
and purified with phosphocellulose, gel filtration, S-Sepharose 
and AF-Heparin column chromatography. The molecular mass 
of the enzyme was determined to be 32 kDa by gel filtration and 
activity staining on SDS-PAGE. The enzyme is a Ser/Thr protein 
kinase phosphorylating tau, l~-tubulin, MAP2 and ~-casein. Em- 
ploying many synthetic peptides, the recognition site of this en- 
zyme appears to be -SR- .  The enzyme requires no second mes- 
senger and is inhibited with high concentration of heparin, but not 
by inhibitors of CKI. These results indicate that this enzyme, 
tau-tubulin kinase is novel and distinct from TPKI, II and CKI, 
II. 
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I. Introduction 
We have previously reported that tau protein kinases I and 
II (TPKI, -II) from bovine brain extract phosphorylate tau and 
form paired helical filament (PHF) epitopes [1-3]. Although 
phosphorylation of tau by TPKI  and -II was stimulated by 
tubulin under the conditions of microtuble formation, these 
enzymes have no ability to phosphorylate tubulin [1]. In the 
course of the purification of TPKI  and -II, we found a novel 
tau protein kinase which phosphorylates both tubulin and tau. 
The enzyme, tau-tubulin kinase (TTK) was purified primarily 
as a microtuble associated protein (MAP). However, TTK  was 
also found in the supernatant when separated from microtubles 
using temperature-dependent polymerization and depolymeri- 
zation method. 
It is known that cAMP-dependent protein kinase, calmod- 
ulin kinase and casein kinase (CK) II phosphorylate tubulin 
[4-6]. Recently, it has been reported that casein kinase-like 
kinases from a neuronal cell line PC12 and bovine brain phos- 
phorylate fl-tubulin, but not the CKII-specific synthetic peptide 
[7]. The molecular mass of these enzymes are different from 
TTK and there is no description on tau phosphorylation. 
The characterization f TTK will clarify its role in the phos- 
phorylation of tau and tubulin and may contribute to the eluci- 
dation of the possible roles of microtubles and PHF-tau forma- 
tion. In this paper, the purification and the properties of TTK 
are described and the phosphorylation site sequence for TTK 
was determined. 
*Corresponding author. Fax: (81) (427) 29-6317. 
Abbreviations." PHF, paired helical filaments; TTK, tau-tubulin kinase: 
TPK, tau protein kinase; CK, casein kinase; MAP, microtuble-associ- 
ated protein; SDS, sodium dodecyl sulfate; PTH, phenylthiohydantoin. 
2. Materials and methods 
2.1. Materials 
Adult bovine brains were obtained from the Nakashibetsu prepara- 
tion center, Mitsubishi Kagaku Co. Tau, tubulin and MAP2 were 
prepared from bovine brain extracts [1,8]. Tau peptides K1, K2, K3 and 
4 repeat, p25 protein peptides and their analogs, glycogen synthase 
peptide GS-l were synthesized chemically with the solid phase method, 
on a Biosearch model 9500 or ABI model 431A peptide synthesizer 
[8 11]. In accordance with the amino acid numbering of human tau, the 
sequences of K1, K2, K3, and 4 repeat were found in the regions of 
168-182, 133-166, 307-349 and 194-224, respectively. Peptides, 8655, 
8656 and 8669 were obtained from Funakoshi. Most chemicals, except 
where noted, were obtained from Sigma. 
2.2. Preparation of bovine brain extract 
Bovine brains were homogenized in buffer A (100 mM MES-NaOH, 
pH 6.5, 0,5 mM Mg-acetate, 1 mM EGTA) and treated with assembly 
disassembly cycles to prepare MAPs as described previously [1], The 
MAP fractions were used for the preparation of TPKI and -II [1]. 
While, the supernatant eliminating MAP fractions was used to prepare 
TTK. During the purification, all buffer solutions contained 0.02% 
Tween 20, 10% glycerol, 5 mM 2-mercaptoethernol, 0.1 mM phen- 
ylmethylsulfonyl fluoride, 1 ¢tg/ml eupeptin, 1,ug/ml pepstatin, and 
1/~g/ml antipain. 
2.3. Kinase detection assays 
Phosphorylation ftau and other substrates were measured by quan- 
tifying the radioactive phosphate incorporated from [y-3Zp]ATP (Amer- 
sham) into the substrates at 37°C as described previously [8]. The 
reaction mixture contained 600 ~tM [~'-32p]ATP, substrate (0.3-0.6 mg/ 
ml) in buffer B (100 mM MES-NaOH, pH 6.5, 5 mM Mg-acetate, 
1 mM EGTA). In case of synthetic peptides, the reaction mixture con- 
tained 600/~M [~/-32p]ATP, 0.66 mg peptide in buffer A. One unit of 
the kinase was defined as the amount of the enzyme required to incor- 
porate 1 pmol of 32p into the substrate in 1 min at 37°C. The protein 
concentration was measured spectrophotometrically ssuming that 
1 absorbance unit at 280 nm is equal to 1 mg/ml. 
Kinase activity staining on SDS-PAGE was done using the gel con- 
taining 0.4 mg/ml tau or 0.8 mg/ml tubulin by the method of Kameshita 
and Fujisawa [12]. The kinase was also detected by phosphorylation 
with [y-32p]ATP, followed by SDS-PAGE and autoradiography. 
2.4. SDS-poly acrlyamide slab gel electrophoresis 
SDS-PAGE was carried out with a 3% stacking gel and a 10% 
resolving el. Gels were stained with Coomassie brilliant blue R250 or 
2D-silver stain II (Daiichi Pure Chemicals). For autoradiography the 
gels were dried in vacuum and exposed to Kodak Omat RPI 6 film at 
- 80oc. 
2.5. Determination of phosphorylation sites in the synthetic peptide-F5b 
For analysis to distinguish phospho-Ser f om Ser, a modified se- 
quencing protocol was used [13]. Phospho-Ser quantitatively forms 
dehydroalanine, followed by an addition reaction with DTT, yielding 
a DTT adduct of phenylthiohydantoin (PTH) dehydroalanine, while, 
Ser yields both PTH-serine and DTT adduct of PTH-dehydroalanine. 
The chemically synthesized peptide F5b was maximally phosphorylated 
with TTK. The phosphorylated peptide was sequenced and the result 
was compared with that of non-phosphorylated F5b which gave the 
ratio of PTH-serine and PTH-dehydroalanine 3 : 1 at normal serine site 
of cycle 4. While the phosphorylated peptide gave the ratio of those 
1 : 1.8, indicating that the 4th serine is phosphorylated byTTK. 
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buffer (20 mM MES-NaOH, pH 6.8, 5 mM Mg-acetate, and 
1 mM EGTA). The gel was washed with PC buffer containing 
0.1 M NaC1 and packed on a column (3.6 × 30 cm) with the 
same buffer• Column chromatography was carried out using 
linear gradient with a 1000 ml of 0.1-1.0 M NaCI in PC buffer. 
Tubulin phosphorylating activity eluted between 0.3-0.5 M 
NaCI. This kinase fraction was loaded onto a S-Sepharose 
(Pharmacia LKB Biotechnology AB) column (1.7 × 9.0 cm) 
equilibrated with PC buffer. The column was washed with 100 
ml of the same buffer and then with 100 ml of 20 mM HEPES- 
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NaOH, pH 8.2, containing 5 mM Mg-acetate, 1 mM EGTA 
and 0.05 M NaC1. A 200 ml linear salt gradient of 0.05-0.3 M 
NaC1 in the same buffer was used to fractionate proteins. The 
kinase luted at 0.25 M NaC1. The active fractions were concen- 
trated with YM 10 Diaflo membrane (Amicon) and applied on 
a G3000 SW column of HPLC (Tosoh; 7.5 × 600 mm), equili- 
brated with 0.3 M NaC1 in buffer B. Fractions 2 ml were 
collected. The kinase eluted at the molecular mass of about 32 
kDa (Fr.78) as shown in Fig. IA. The active fractions (Fr.77- 
79) were loaded onto a AF-heparin Toyopeal 650 column 
(Tosoh; 0.7 x 1.5 cm) in sodium phosphate buffer (20 mM so- 
dium phosphate, pH 7.6, 5 mM Mg-acetate, 1 mM EGTA). The 
chromatography was carried out with a series of step elution 
with 0.03 M, 0.07 M, 0.11 M, 0.15 M, 0.19 M, 0.23 M, 0.27 M, 
0.31 M, 0.35 M (2 ml each) and 0.4 M, 0.45 M (l ml each) and 
finally 0.5 M NaCI. Fractions of 1 ml were collected. Tau and 
tubulin phosphorylating activities were eluted as a single peak 
(Fr.17-19) at 0.5 M NaC1 as shown in Fig. lB. The silver 
staining patterns indicated that the protein band of TTK corre- 
sponds to one of two bands migrating slightly slower than the 
28 kDa marker protein (Fig. 1C). To determine which protein 
is the enzyme, phosphorylation a d activity staining on SDS- 
PAGE were carried out. Although further purification by 2nd 
HPLC with a G3000 SW column was tried on Fr.18 of AF- 
heparin, it was difficult to increase the specific activity. As 
shown in Fig. 2A and B, the band at 32 kDa and other bands 
Fig. 1. (A) HPLC on G3000SW column of TTK. The arrows indicate 
the position of markers, lactate dehydrogenase (140 kDa), bovine 
serum albumin (68 kDa), ovalbumin (43 kDa) and ATP, from left to 
right. A280 (--). (B) AF-heparin column chromatography of TTK. The 
kinase activity was assayed with tau (e) and tubulin (©) as described 
in section 2. (C) SDS-PAGE of AF-heparin eluates. Aliquots (6/tl) were 
subjected to SDS-PAGE and the gel was stained with silver stain. 
Fraction umbers are indicated above ach lane. M = pre-stained mo- 
lecular weight markers (BRL). 
3. Results 
3.1. Purification of  TTK from bovine brain extract 
Brain extract was prepared from 15 bovine brains. The su- 
pernatant of MAPs fractions was mixed with phosphocellulose 
(Pl l ;  Whatman) gel slurry previously equilibrated with PC 
were phosphorylated. However, the activity staining with tau 
or tubulin showed only a protein at 32 kDa phosphorylated the 
substrate (Fig. 2C,D). These results indicate that the band at 
32 kDa is TTK. The purification procedure is summarized in 
Table 1. Significant separation of TTK activity from other tau 
phosphorylating kinases uch as TPKI and -II occurred mainly 
with S-Sepharose column chromatography. Thereafter, the ac- 
tivity ratio on tau/tubulin became constant. The yield is calcu- 
lated as based on tubulin phosphorylating activity. Unless oth- 
erwise noted, Fr.19 of AF-heparin column was used as the 
enzyme for the characterization experiments of TTK. 
3.2. Catalytic properties of  TTK 
TTK phosphorylation activity had an optimum pH range of 
5.5-6.0 in Tris-acetate buffer. The Km for phosphorylation of
Table 1 
Purification of tau-tubulin kinase 
Step Protein Total activity Activity ratio Specific activity Yield (%) 
(rag) tau/tubulin tau/tubulin tau/tubulin 
(pmol/min) (pmol/min/mg) 
(1) Phosphocellulose 70 30,415/15,435 1.9 289/147 (100) 
(2) S-Sepharose 15 2,940/2,634 1.1 196/176 (17.1) 
(3) Gel Filtration 0.48 2,244/1,596 1.4 3,740/2,660 (10.3) 
(4) Heparin 0.02 765/528 1.3 16,650/13,250 (3.4) 
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Fig. 2. Detection of TTK in SDS-PAGE. (A) Aliquots were labeled with [g-32p]ATP and gel was stained with silver stain. Lane 1 = second gel filtration 
fraction of AF-heparin Fr.18, 13 ¢tl; lane 2, AF-heparin Fr.19, 6 #l; M, marker proteins; B, butler blank. (B) Autoradiography of (A). (C,D) 
Phosphorylating activity in TTK fraction (15 #1) was detected by kinase activity staining of tau (C) or tubulin (D) included in the gel. Lane 1 = second 
gel filtration fraction of AF-heparin Fr.18; lane 2 = AF-heparin Fr.19; M, marker proteins. 
tau is 12.5 #M and the Km for ATP was 27 #M. The optimum 
Mg 2+ concentration ranged from 1-20 mM toward general sub- 
strates, but a low level of 0.5 mM toward peptide substrates. 
Second messengers such as cAMP and calmodulin were deter- 
mined to be unnecessary, as far as we examined (data not 
shown). As shown in Fig. 3A, the optimum concentration of 
K + is below 10 mM for tau, but 200 mM for tubulin. Inhibitors 
for casein kinase I, CKI-7, CKI-8 and hemin had no effect on 
TTK. However, heparin did show an inhibitory effect as shown 
in Fig. 3B. The ICs0 for heparin was 6 #M, about 600-fold high 
than the 9.3 nM for CKII inhibition [15]. At 6 #M heparin, 
TPKI activity was actually stimulated. 
3.3. Substrate specificity of TTK 
P~ incorporation i to tau and tubulin by TTK was estimated 
to be 6-7 and l-2 mol/mol substrate, respectively (Fig. 4A). 
Phosphorylated amino acids were determined tobe Ser and Thr 
(Fig. 4B), therefore the enzyme is a Ser/Thr protein kinase. 
Phosphorylated tubulin was confirmed to be fl-tubulin by au- 
toradiography on SDS-PAGE (Fig. 5). 
As shown in Table 2, TTK phosphorylates proteins uch as 
MAP2 and or-casein as well as tau and tubulin, but not fl-casein 
and histone H1, H2a, H2b which have been previously identi- 
fied as substrates for TPKII [1]. 
Table 2 
TTK activity toward various substrates 
Substrate Activity (pmol/mirdpg) 
Tau 20.0 
Tubulin 14.5 
MAP2 22.2 
~-Casein 14.0 
#-Casein N.G. 
Neurofilament N.G. 
Histone H1 0.3 
Histone H2a 0.15 
Histone H2b 0.30 
3.4. Phosphorylation site sequence of TTK 
Several synthetic peptides, the designs of which were based 
on the sequence of tau, glycogen synthase and brain specific 
protein p25, were checked to identify the sequence required to 
be substrates for TTK (Table 3A). Synthetic peptides contain- 
ing Ser-Arg sequences required to be substrates for TTK. 
Among these peptides hown in Table 3A, F5b, one of the 
peptides from p25 is a good substrate. However, apeptide (F5a) 
related to F5b except for the absence of 7 amino acids at its 
N-terminus was not phosphorylated. The result suggests that 
the 4th Ser of F5b peptide is phosphorylated. The phosphoryl- 
ation site of F5b was identified as the 4th Ser by sequencing of 
phospho-serine (Fig. 6). 
Furthermore, the phosphorylation site sequence of TTK was 
examined using synthetic peptides. A peptide composed of the 
N-terminal 7 amino acids of F5b was expected to be a good 
substrates for TTK. Therefore, the peptide F5n was synthesized 
and tested for its ability to act as a substrate for TTK. Surpris- 
ingly, as shown in Table 3B, the peptide F5n was not 
phosphorylated byTTK. Peptides containing either 3 (F5d) or 
8 (F5f) additional amino acids were synthesized. Although pep- 
tide, F5d does not work as the substrate, F5f was 
phosphorylated at the one-third intensity of F5b. These results 
suggest hat the whole sequence of FSb is necessary for the 
better substrate. 
Two peptides 8655 and 8669, which are known to be sub- 
strates for cGMP-dependent protein kinase and have Ser-Arg 
sequence, were examined. Both peptides were for the substrates 
of TTK. The analog 8656 was used as a negative control. This 
result suggests that an RSR-  motif may be an effective sub- 
strate for TTK. Peptide F5h, identical to F5n except for re- 
placement of D of position 3 with R, was found to be as good 
a substrate as F5b. But, when an Arg was substituted for Met 
(F5g) or a Glu (F5e) was added to the C-terminus, only inactive 
substrates were obtained. These results indicate-SR sequence 
is necessary, but not sufficient for a substrate for TTK. 
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Fig. 3. Effects of KCI and heparin on TTK activity. (A) Effect of KC1 
concentrations. The activity toward tau (e) and tubulin (o) was assayed 
at various concentrations of KCI. (B) Effects of heparin at various 
concentrations were compared with TTK (e) and TPKI (o) activities 
on tau. 
4. Discussion 
TTK was found in bovine brain and phosphorylates tau, 
MAP2, tubulin and m-casein. TTK is a Ser/Thr protein kinase 
and distinct from TPKI and -II which are unable to phospho- 
rylate tubulin. Although TTK was first found in MAPs from 
bovine brain together with TPKI and -II, the MAP-free super- 
natant was also useful as a source of TTK. Therefore, TTK 
does not necessarily bind specifically to microtubles. 
TTK is also distinct from CKI and -II. TTK does not phos- 
phorylate a CKII-specific synthetic peptide and is not inhibited 
by heparin at low concentration that do inhibit CKI1. Inhib- 
itors of CK1 are also not effective in inhibiting the activity of 
TTK. It has been reported that a heparin-inhibited protein 
kinase from bovine kidney phosphorylates casein and has a 
molecular mass of 32 kDa on gel filtration. However, the sub- 
strate specificitey for tau and tubulin are unknown [16]. The 32 
kDa molecular mass of TTK is distinct from the subunit molec- 
ular masses of CKII (38 kDa, 36 kDa and 25 kDa) [17]. It has 
been reported that CKII phosphorylates tubulin in addition to 
casein and phosphorylation is regulated by a neuronal protein 
of 185 kDa [18]. Recently, Crute and Buskirk have reported 
that several tubulin casein kinase activities copurified with tu- 
bulin from bovine brain [7]. These tubulin casein kinases 
phosphorylated both tubulin and casein, but none was able to 
phosphorylate he CKII-specific synthetic peptide RRREEET- 
EEE. Although they did not report studies on phosphorylation 
of tau by the tubulin kinases, it would be interesting to know 
the recognition sites of these enzymes. 
The results reported here indicate that TTK requires an Arg 
residue immediately C-terminal to the phosphorylatable resi- 
due, an -SR-  motif (Table 3A,B, Fig. 6). TTK modifies about 
6 residues of S/T in tau and 1-2 residues in fl-tubulin (Fig. 4). 
A,  8 -  
6' 
4' 
o ==. 
0= 
c 2" 
E 
O( 
0 
A A 
I le le l l l l l l l a l l l l  0 
D,,  0 ....... 0 ........ 
1 '0 2'0 3'0 
Time (h) 
B.  P-Ser 
P-Thr 
P-Tyr 
Partially hydrolyzed 
peptides 
Origine Substrate: Tau Tubulin 
First 
4- 
T 
Second 
Fig. 4. Phosphorylation f tau and tubulin by TTK. (A) The phospho- 
rylation of tau (e) and tubulin (o) was monitored as a function of time. 
(B) Phospho-amino acids of 32p-labeled tau, tubulin and K2 peptide 
were hydrolyzed and analyzed with two-dimensional electrophoresis. 
First dimension: acetic acid/formic acid/H20 (78:25:897), pH 2.0 at 
450 V for 1 h; 2nd dimension, acetic acid/pyridine/H20 (5 : 5 : 945), pH 
3.5, at 450 V for 3 h, The radio labeled amino acids were detected by 
autoradiography. The positions of the phosphorylated amino acid 
standards were visualized by ninhydrin staining as shown with dotted 
circles. 
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Fig. 5. Time course of phosphorylation ffl-tubulin by TTK. Tubulin (~ and fl) was phosphorylated by TTK and the reaction products from various 
time were subjected on 7% SDS-PAGE according to the method of Serrano et al. [6]. The gel was stained with CBB (A) and the radio-labeled products 
were detected by autoradiography (B). M, standard markers. 
Bovine tau contains 5 residues o f -S /TR  sequences [19], fl- 
tubulin has only one-SR-  sequence [20] and cc-tubulin has none 
[21]. These data seem to agree with the number of phosphoryl- 
ation sites by TTK. Although Ser-4 of F5b fragment of p25 
protein was phosphorylated, F5n, F5e and F5g peptides, which 
contain the same Ser-4 residue, are poor substrates. These facts 
indicate a requirement for a larger structure for recognition and 
phosphorylation by TTK. 
A list of phosphorylation site sequences for many protein 
kinases have been reported [22]. Protein kinases, which recog- 
nize the -S/TR-motif as a consensus for phosphorylation sites, 
is unknown. In this category there are enzymes which phospho- 
rylate -S/TR-sequences such as CKI and GSK-3, cAMP-de- 
pendent protein kinase and cGMP-dependent protein kinase, 
hem-regulated lF-2~-kinase, p68 kinase and protein kinase C. 
PHF-tau accumulate in the brain of Alzheimer's disease pa- 
tients and the main component is tau [23-25]. It has been 
reported that PHF-tau is highly phosphorylated in the tau 1 
portion [26] and carboxy-terminal portion [27]. Recently 19 
phosphorylation sites in PHF-tau have been identified, 10 of 
Table 3 
(A) TTK activity toward synthetic peptides 
Protein/fragment Amino acid sequence Activity (pmol/min/#g) 
tau/Kl VAVVRTPPKSPSSAK 0.05 
tau/K2 PKSGDRSGYSSPGS PGTPGSRSRTPSLPTPPTREPK 0.60 
tau/K3 PVVS SGDTS PRHLSNVSSTGS IDMVDS PQLATLADEVSASLAK 0.09 
tau/4 repeat DLKNVKSKIGSTENLKHQPGGGKVQ I INKKL 0.10 
p25/F3 KAUS S PTVSRKTD 0.70 
p25/F5a PANKTPPKS PGEPAKDPAAK 0.10 
p25/F5b MADSRPKPANKT PPKS PGE PAKD PAAK 7.80 
GS/GS-I YRRAAVPPS PSL_SRHSS PHQSESEE 0.40 
CKI|  subst ra te  RRREEETEEE 0.10 
Ser of-SR motif is underlined. 
(B) Substrate specificity of TTK 
Peptide Amino acid sequences Activity (pmol/min/#g) (%) 
F5b MADSRPKPANKT PPKS PGE PAKDPAAK 8.2 I00 
F5a PANKTPPKS PGEPAKDPAAK 0 0 
F5n MADSRPK 0 0 
F5d MADSRPKPAN 0 0 
F5f MADSRPKPANKTPPK 2.7 33 
F5e MADSRPAE 0 0 
F5g RADSRPK 0.7 9 
F5h MARSRPK 7.5 92 
8655 RKRSRKE 2.8 34 
8659 RKRSRAE 8. l 99 
8656 RKRARKE 0 0 
Ser of-SR-motif is underlined. 
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Fig. 6. Comparison of sequencing profiles of phospho-serine and the 
corresponding on-phospho-serine of F5b peptide in cycle 4. F5b pep- 
tide was phosphorylated byTTK (A) and the sequences were analyzed 
to compare with the non-phosphorylated p ptide (B). S and S' indicate 
elution position of PTH-serine and PTH-dehydroalanine  4th cycle 
of the analysis, respectively. 
them are proline-directed sites, the remainder are non-proline 
sites [28], Among the non-proline-directed phosphorylation 
sites there are Ser-208 and Ser-210, which have -SR-motif  and 
are located in K2 fragment/tau 1 portion. TTK phosphorylates 
K2 fragment as shown in Table 3A and Fig. 4B. The exact 
phosphorylation sites have not been determined, but it seems 
likely that TTK  phosphorylates no other sequence than Ser-208 
and Ser-210, -SR-motif  of K2. 
Initially, TPK was identified as a tubulin-dependent protein 
kinase [29] and it was confirmed that phosphorylation byTPKI  
and -II was stimulated in the presence of tubulin [1]. It is not 
known yet how tubulin stimulates TPKI and -II activities. It 
has been reported that the phosphorylation of MAP2 and tau 
results in the inhibition of microtuble assembly [30]. We are 
interested in the phosphorylation of tubulin and tau by TTK 
in the presence of TPKI  and -II and the interactions related to 
microtuble assembly. This may aid in elucidating PHF forma- 
tion in Alzheimer disease brain. 
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